135 related articles for article (PubMed ID: 22648504)
1. Environment and genetics: Making sense of the noise.
Petherick A
Nature; 2012 May; 485(7400):S64-5. PubMed ID: 22648504
[No Abstract] [Full Text] [Related]
2. Models of genetic susceptibility to breast cancer.
Antoniou AC; Easton DF
Oncogene; 2006 Sep; 25(43):5898-905. PubMed ID: 16998504
[TBL] [Abstract][Full Text] [Related]
3. Can a computer-based system be used to educate women on genetic testing for breast cancer susceptibility?
Schwartz MD; Tercyak KP; Peshkin BN; Valdimarsdottir H
Nat Clin Pract Oncol; 2005 Jan; 2(1):24-5. PubMed ID: 16264852
[No Abstract] [Full Text] [Related]
4. Genetics: Relative risk.
Velasquez-Manoff M
Nature; 2015 Nov; 527(7578):S116-7. PubMed ID: 26580161
[No Abstract] [Full Text] [Related]
5. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2: to test or not to test.
Brandt RT; Lynch HT
Breast Cancer Res Treat; 2001 May; 67(2):187-8. PubMed ID: 11519868
[No Abstract] [Full Text] [Related]
7. Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.
Chang-Claude J; Andrieu N; Rookus M; Brohet R; Antoniou AC; Peock S; Davidson R; Izatt L; Cole T; Noguès C; Luporsi E; Huiart L; Hoogerbrugge N; Van Leeuwen FE; Osorio A; Eyfjord J; Radice P; Goldgar DE; Easton DF; ; ; ;
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):740-6. PubMed ID: 17416765
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement and breast cancer.
Castiglione-Gertsch M
Ann Oncol; 2004; 15 Suppl 4():iv275-7. PubMed ID: 15477320
[No Abstract] [Full Text] [Related]
9. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
Gronwald J; Tung N; Foulkes WD; Offit K; Gershoni R; Daly M; Kim-Sing C; Olsson H; Ainsworth P; Eisen A; Saal H; Friedman E; Olopade O; Osborne M; Weitzel J; Lynch H; Ghadirian P; Lubinski J; Sun P; Narod SA;
Int J Cancer; 2006 May; 118(9):2281-4. PubMed ID: 16331614
[TBL] [Abstract][Full Text] [Related]
11. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
Aloraifi F; Boland MR; Green AJ; Geraghty JG
Surg Oncol; 2015 Jun; 24(2):100-9. PubMed ID: 25936246
[TBL] [Abstract][Full Text] [Related]
12. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance.
Skol AD; Sasaki MM; Onel K
Breast Cancer Res; 2016 Oct; 18(1):99. PubMed ID: 27716388
[TBL] [Abstract][Full Text] [Related]
13. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.
Pasacreta JV
Cancer Invest; 2003; 21(4):588-623. PubMed ID: 14533449
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic.
Shih HA; Couch FJ; Nathanson KL; Blackwood MA; Rebbeck TR; Armstrong KA; Calzone K; Stopfer J; Seal S; Stratton MR; Weber BL
J Clin Oncol; 2002 Feb; 20(4):994-9. PubMed ID: 11844822
[TBL] [Abstract][Full Text] [Related]
16. The twilight zone between health and sickness: a qualitative exploration with asymptomatic BRCA1 and 2 mutation carriers.
Dagan E; Goldblatt H
Women Health; 2009 Jun; 49(4):263-79. PubMed ID: 19753503
[TBL] [Abstract][Full Text] [Related]
17. Genetics of breast cancer: contribution of BRCA1/2 genes alterations to hereditary predisposition.
Branković-Magić M; Dobricić J; Krivokuća A
Vojnosanit Pregl; 2012 Aug; 69(8):700-6. PubMed ID: 22924267
[No Abstract] [Full Text] [Related]
18. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.
de Jong MM; Nolte IM; te Meerman GJ; van der Graaf WT; Oosterwijk JC; Kleibeuker JH; Schaapveld M; de Vries EG
J Med Genet; 2002 Apr; 39(4):225-42. PubMed ID: 11950848
[TBL] [Abstract][Full Text] [Related]
19. Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany.
Hamann U; Liu X; Lange S; Ulmer HU; Benner A; Scott RJ
J Med Genet; 2002 Mar; 39(3):E12. PubMed ID: 11897832
[No Abstract] [Full Text] [Related]
20. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
